Clarus Ventures closes third fund at $500 mln

Clarus Ventures, a life sciences venture firm, raised $500 million for its third fund, sweeping past its initial $375 million target.

9 June 2015•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail